| Name | Title | Contact Details |
|---|
Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.
Wimbledon Health Partners formed in 2013 to meet the need for on-site diagnostic testing at physicians’ offices. The industry leader, Wimbledon Health Partners provides physicians with state-of-the-art, in-office testing to detect circulatory conditions using vascular ultrasound and electro- and echocardiography. Nerve conduction velocity testing is also used to support diagnosis of problems related to the nervous and muscular systems. Wimbledon Athletics, the newest division of Wimbledon Health Partners, is pioneering the way for high schools, colleges and universities to test students for unsuspected heart abnormalities to help minimize sudden cardiac death among young athletes.
Med MatRx is a Monaca, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Clearview Healthcare Partners is a Newton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ōmcare is a digital health company that aims to change the way the world cares by extending the reach of caregivers, increasing medication adherence, and improving treatment outcomes through the power of remote care and two-way video technology. By partnering with pharmacies, payers, providers, and family caregivers, Ōmcare strives to help people live healthier, more vibrant, independent lives and reduce healthcare cost. Ōmcare`s first product is called the Ōmcare Home Health Hub - a web-enabled platform that dispenses medication and provides two-way, audiovisual confirmation of medication adherence while facilitating social interaction and remote telehealth care. Ōmcare exists due to the rapidly aging population; high rate of medication nonadherence; a shortage of family and professional caregivers; continued increase in health care costs; consumer preference for in-home care and aging in place; changing reimbursement for home care services; and advancements remote monitoring and wearable technology.